Integration of Treatment for COVID Achieves 84% Recovery Rate 基隆長庚中西醫合治新冠 痊癒率達84%

There has been a breakthrough in the treatment of COVID-19! Employing a treatment protocol integrating traditional Chinese medicine and western medicine, Keelung Chang Gung Hospital researched 93 COVID-19 patients and discovered that of those receiving the integrated treatment, the mortality rate is 15 percent, while the recovery rate is up to 84 percent. In addition, not only Chingguan Yihau but also the Chinese medicine astragalus compound YQ1 can also enhance the anti-viral capability.


Keelung City bore the brunt of the catastrophic outbreak of COVID-19 in May. Residents' infection rate reached 21 percent, being the nation's number one. Keelung Chang Gung Hospital Research Team targeted 93 COVID-19 patients hospitalized from May to July, among which 29 patients were treated with integration of traditional Chinese medicine and western medicine, while the other 64 were treated with routine western medicine. The results showed that the mortality rate of those who received the integrated treatment was only 15 percent, while the recovery rate was 84 percent. On the other hand, the mortality rate of the other group was 40 percent, and the recovery rate at 60 percent. Not only Chingguan Yihau but the Chinese medicine astragalus compound YQ1 can also raise anti-viral capability.

Huang Tsu-hung, Doctor, Dept. of Chinese Medicine, Keelung Chang Gung Hospital: “Astragalus (huangqi) helps with invigorating and nourishing blood, so it actually compensates for side effects from these other clearing heat and detox medicine. And huangqi itself also provides proper adjustment to the immune system.”

Moreover, according to the National Health Insurance Administration, in the first half of the year, those infected who were treated in hospitals within half a year of infection exceeded 4.51 million people, and most exhibit respiratory symptoms. Experts estimate that at least 500,000 people domestically would develop Long-COVID.

Yu Chu-chieh, Doctor, Thoracic Department, Keelung Chang Gung Hospital: “The most common symptom is coughing, chronic cough. But aside from that, we also see the tightness of the chest, panting and being out of breath while walking, as well as heart palpitations.”

Doctor note that Long-COVID exhibits quite diverse symptoms. If symptoms develop and persist for two months after three months of infection and are not diagnosed with any other known illnesses or disorders, then it is deemed Long-COVID. It is recommended that such recovered patients may go get checked in hospitals to obtain the correct medication and treatment, alleviating after effects of Long-COVID.

 

 

 

今年5月新冠本土疫情大爆發,以基隆市首當其衝,市民確診率21%居全國之冠,基隆長庚醫院研究團隊針對5月到7月收治93位確診住院病患做研究,其中29位是中西醫整合治療,對照組64位則是以西醫常規治療,結果發現,接受中西醫治療病人組,死亡率僅有1成5,痊癒率高達8成4,對照組死亡率則有4成,痊癒率6成,而且不只清冠一號,中藥黃耆複方YQ1也能提高抗病毒能力。

基隆長庚中醫科醫師黃澤宏指出:「黃耆它有補氣的效果,那是不是它就可以彌補掉這些,清熱解毒藥的一些不良反應,甚至黃耆這個藥本身有很好的免疫調節作用。」

此外,根據健保署統計,今年上半年確診半年內就醫者超過451萬人次,主要以呼吸道症狀為主,有專家推估,國內至少有50萬人出現「長新冠」。

基隆長庚胸腔科醫師于鍾傑表示:「最常見的症狀是咳嗽啦,比較久咳,那當然除了咳嗽之外,我們常見的症狀有包括胸悶、會喘、走路會喘、還有心悸。」

醫師表示,長新冠表現相當多元,如果染疫3個月後出現症狀、持續2個月以上且無法用其他疾病診斷,就可視為長新冠,建議康復者可以到醫院整合醫療門診就醫對症下藥,以減緩長新冠後遺症。
 

全台敬老金大調查

相關新聞